SkinBioTherapeutics (GB:SBTX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
In a significant update from SkinBioTherapeutics PLC, David Campbell Brierwood has crossed a threshold in voting rights, now holding 3.1% of the company with 6,998,305 total voting rights as of August 12, 2024. This change in shareholding structure was formally notified to the company on the following day. No voting rights are held through financial instruments, indicating a straightforward equity stake.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.